90 related articles for article (PubMed ID: 15867393)
21. Tumor necrosis factor-alpha modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures.
Bernardino L; Agasse F; Silva B; Ferreira R; Grade S; Malva JO
Stem Cells; 2008 Sep; 26(9):2361-71. PubMed ID: 18583543
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level.
Lim S; Ryu J; Shin JA; Shin MJ; Ahn YK; Kim JJ; Han KH
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2138-45. PubMed ID: 19745197
[TBL] [Abstract][Full Text] [Related]
23. Clioquinol promotes cancer cell toxicity through tumor necrosis factor alpha release from macrophages.
Du T; Filiz G; Caragounis A; Crouch PJ; White AR
J Pharmacol Exp Ther; 2008 Jan; 324(1):360-7. PubMed ID: 17940196
[TBL] [Abstract][Full Text] [Related]
24. Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer.
Bertilaccio MT; Grioni M; Sutherland BW; Degl'Innocenti E; Freschi M; Jachetti E; Greenberg NM; Corti A; Bellone M
Prostate; 2008 Jul; 68(10):1105-15. PubMed ID: 18437689
[TBL] [Abstract][Full Text] [Related]
25. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X
Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
[TBL] [Abstract][Full Text] [Related]
27. Low-density lipoprotein receptor-related protein contributes to the antiangiogenic activity of thrombospondin-2 in a murine glioma model.
Fears CY; Grammer JR; Stewart JE; Annis DS; Mosher DF; Bornstein P; Gladson CL
Cancer Res; 2005 Oct; 65(20):9338-46. PubMed ID: 16230396
[TBL] [Abstract][Full Text] [Related]
28. Independent activation of Akt and NF-kappaB pathways and their role in resistance to TNF-alpha mediated cytotoxicity in gliomas.
Sudheerkumar P; Shiras A; Das G; Jagtap JC; Prasad V; Shastry P
Mol Carcinog; 2008 Feb; 47(2):126-36. PubMed ID: 17849421
[TBL] [Abstract][Full Text] [Related]
29. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch.
Lee H; Baek S; Joe SJ; Pyo SN
Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
Imre G; Gekeler V; Leja A; Beckers T; Boehm M
Cancer Res; 2006 May; 66(10):5409-18. PubMed ID: 16707469
[TBL] [Abstract][Full Text] [Related]
31. Differential dependence of the ingestion of necrotic cells and TNF-alpha / IL-1beta production by murine macrophages on lipid rafts.
Acosta-Pérez G; Maximina Bertha Moreno-Altamirano M; Rodríguez-Luna G; Javier Sánchez-Garcia F
Scand J Immunol; 2008 Oct; 68(4):423-9. PubMed ID: 18782272
[TBL] [Abstract][Full Text] [Related]
32. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats.
Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H
Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472
[TBL] [Abstract][Full Text] [Related]
33. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice.
Gao X; Belmadani S; Picchi A; Xu X; Potter BJ; Tewari-Singh N; Capobianco S; Chilian WM; Zhang C
Circulation; 2007 Jan; 115(2):245-54. PubMed ID: 17200442
[TBL] [Abstract][Full Text] [Related]
35. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma.
Yi L; Xiao H; Xu M; Ye X; Hu J; Li F; Li M; Luo C; Yu S; Bian X; Feng H
J Neuroimmunol; 2011 Mar; 232(1-2):75-82. PubMed ID: 21056915
[TBL] [Abstract][Full Text] [Related]
36. Macrophage Ablation Reduces M2-Like Populations and Jeopardizes Tumor Growth in a MAFIA-Based Glioma Model.
Gabrusiewicz K; Hossain MB; Cortes-Santiago N; Fan X; Kaminska B; Marini FC; Fueyo J; Gomez-Manzano C
Neoplasia; 2015 Apr; 17(4):374-84. PubMed ID: 25925380
[TBL] [Abstract][Full Text] [Related]
37. [Recording of cell-mediated immunity in patients with gliomatous brain tumors].
Lambrecht R; Willenberg E; Plate M
Z Exp Chir Transplant Kunstliche Organe; 1986; 19(3):167-71. PubMed ID: 3751205
[TBL] [Abstract][Full Text] [Related]
38. GlioM&M: Web-based tool for studying circulating and infiltrating monocytes and macrophages in glioma.
Abels ER; Maas SLN; Tai E; Ting DT; Broekman MLD; Breakefield XO; El Khoury J
Sci Rep; 2020 Jun; 10(1):9898. PubMed ID: 32555306
[TBL] [Abstract][Full Text] [Related]
39. Antitumor activity of recombinant human tumor necrosis factor-alpha (rH-TNF alpha) and liposome-entrapped rH-TNF alpha.
Wakabayashi T; Yoshida J; Ishiyama J; Mizuno M
Neurol Med Chir (Tokyo); 1997 Oct; 37(10):739-45; discussion 745-6. PubMed ID: 9362133
[TBL] [Abstract][Full Text] [Related]
40. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors.
Morantz RA; Wood GW; Foster M; Clark M; Gollahon K
J Neurosurg; 1979 Mar; 50(3):305-11. PubMed ID: 422981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
